This site is intended for healthcare professionals

Phase III ADAPT-PO trial of SPR 994 shows efficacy in complicated urinary tract infection.- Spero Therapeutics

Read time: 1 mins
Last updated:28th Jun 2021
Published:9th Sep 2020
Condition: Infectious Diseases/UTI
Type: drug
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest